Koninklijke Philips N.V. (PHG) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Koninklijke Philips N.V. (PHG) Healthcare & Pipeline Overview

Koninklijke Philips N.V. is a diversified health technology company providing diagnostic imaging, connected care, and personal health solutions. With a global presence and a focus on innovation, Philips competes in the medical devices industry against companies like Teva Pharmaceutical Industries and DexCom, Inc., addressing evolving healthcare needs with a comprehensive product portfolio.

What Is the Investment Thesis for PHG?

Koninklijke Philips N.V. presents a compelling investment case based on its diversified portfolio of health technology solutions and strategic focus on growth markets. With a market capitalization of $27.0B and a P/E ratio of 23.2, Philips demonstrates financial stability and profitability, supported by a gross margin of 45.2% and a profit margin of 5.5%. A key value driver is the company's innovation in diagnostic imaging and connected care, addressing the increasing demand for advanced healthcare technologies. Growth catalysts include strategic partnerships and expansion into emerging markets. However, potential risks include regulatory changes and competition from established players like Mettler-Toledo International Inc. and Teva Pharmaceutical Industries Limited. The company's dividend yield of 3.68% provides an additional incentive for investors.

Based on FMP financials and quantitative analysis

PHG Key Highlights

• Market capitalization of $27.0B reflects substantial investor confidence in Philips' market position.
• P/E ratio of 23.2 indicates a reasonable valuation relative to earnings.
• Gross margin of 45.2% demonstrates efficient cost management and strong pricing power.
• Profit margin of 5.5% signifies profitability in a competitive industry.
• Dividend yield of 3.68% provides a steady income stream for investors.

Who Are PHG's Competitors?

PHG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are PHG's Key Strengths?

• Diversified portfolio of health technology solutions.
• Strong brand recognition and global presence.
• Extensive research and development capabilities.
• Strategic partnerships and collaborations.

What Are PHG's Weaknesses?

• Exposure to regulatory risks and compliance requirements.
• Dependence on healthcare spending and reimbursement policies.
• Competition from established and emerging players.
• Product recalls and safety concerns.

What Could Drive PHG Stock Higher?

• Expansion of digital health solutions and remote patient monitoring capabilities.
• New product launches in diagnostic imaging and personal health segments.
• Strategic partnerships and collaborations to enhance product offerings.
• Regulatory approvals for innovative medical devices in key markets.

What Are the Key Risks for PHG?

• Economic downturns and healthcare budget cuts impacting demand.
• Exposure to regulatory risks and compliance requirements.
• Technological obsolescence and disruptive innovations.
• Product recalls and safety concerns.
• Currency fluctuations affecting ADR value.

What Are the Growth Opportunities for PHG?

• Expansion in Emerging Markets: Philips has a significant opportunity to expand its presence in emerging markets, particularly in Asia and Latin America, where healthcare infrastructure is rapidly developing. These regions present a large and growing demand for diagnostic imaging and connected care solutions. By leveraging its existing partnerships and establishing new distribution channels, Philips can capitalize on this growth, potentially increasing revenue by 15-20% over the next five years.
• Strategic Partnerships and Collaborations: Philips' strategic collaboration with Ibex Medical Analytics Ltd. to promote digital pathology and AI solutions represents a significant growth opportunity. By partnering with innovative companies, Philips can enhance its product offerings and expand its market reach. Further collaborations in areas such as remote patient monitoring and telehealth could drive additional growth, contributing to a 10-15% increase in revenue within three years.
• Innovation in Diagnostic Imaging: The demand for advanced diagnostic imaging solutions is increasing, driven by the need for early and accurate disease detection. Philips' focus on developing innovative technologies, such as detector-based spectral CT solutions and advanced MRI systems, positions it to capture a larger share of the market. Investments in R&D and strategic acquisitions in this area could result in a 20-25% growth in the diagnostic imaging segment over the next five years.
• Connected Care Solutions for Remote Patient Monitoring: The market for remote patient monitoring is expanding due to the increasing prevalence of chronic diseases and the need for cost-effective healthcare delivery. Philips' connected care solutions, including sleep and respiratory care devices and electronic medical record systems, are well-positioned to address this demand. By expanding its remote monitoring capabilities and integrating AI-driven analytics, Philips can achieve a 15-20% growth in this segment over the next three years.
• Personal Health Products and Digital Parental Solutions: Philips' personal health segment, which includes power toothbrushes, infant feeding solutions, and male grooming products, offers a stable and growing revenue stream. The increasing consumer focus on health and wellness, coupled with the rise of digital parental solutions, presents opportunities for Philips to expand its market share. By launching innovative products and leveraging digital marketing strategies, Philips can achieve a 10-15% growth in this segment over the next five years.

What Opportunities Does PHG Have?

• Expansion in emerging markets.
• Growing demand for digital health solutions.
• Increasing prevalence of chronic diseases.
• Advancements in diagnostic imaging and connected care technologies.

What Threats Does PHG Face?

• Economic downturns and healthcare budget cuts.
• Technological obsolescence and disruptive innovations.
• Cybersecurity threats and data breaches.
• Geopolitical instability and trade barriers.

What Are PHG's Competitive Advantages?

• Strong brand reputation and global presence.
• Extensive portfolio of patented technologies and intellectual property.
• Established relationships with key customers and partners.
• Significant investment in research and development.
• Comprehensive service and support network.

What Does PHG Do?

Koninklijke Philips N.V., founded in 1891 in Amsterdam, Netherlands, has evolved from a lighting company to a global leader in health technology. Initially focused on manufacturing light bulbs, Philips expanded into consumer electronics and, eventually, healthcare solutions. This strategic shift culminated in the company changing its name from Koninklijke Philips Electronics N.V. to Koninklijke Philips N.V. in May 2013, reflecting its commitment to the health technology sector. Today, Philips operates through three primary business segments: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses. The Diagnosis & Treatment segment offers advanced imaging solutions like MRI, CT, and X-ray systems, along with interventional systems and diagnostic informatics. The Connected Care segment provides solutions for acute patient management, emergency care, and sleep and respiratory care. The Personal Health segment focuses on consumer products such as power toothbrushes, infant feeding solutions, and male grooming products. Philips has a global presence, serving markets in North America and internationally. Strategic collaborations, such as those with Ibex Medical Analytics and NICO.LAB, enhance its offerings in digital pathology and AI-driven healthcare solutions. With a workforce of 67,247 employees, Philips continues to innovate and adapt to the changing landscape of healthcare technology.

What Products and Services Does PHG Offer?

• Develops and markets diagnostic imaging solutions, including MRI, CT, and X-ray systems.
• Provides connected care solutions for acute patient management and emergency care.
• Offers sleep and respiratory care solutions for patients with sleep disorders and respiratory conditions.
• Manufactures and sells personal health products, such as power toothbrushes and infant feeding solutions.
• Provides electronic medical record and care management solutions for healthcare providers.
• Offers molecular and hybrid imaging solutions for nuclear medicine.
• Provides integrated interventional systems for minimally invasive procedures.

How Does PHG Make Money?

• Sells diagnostic imaging equipment and related services to hospitals and clinics.
• Provides connected care solutions through a combination of hardware, software, and services.
• Generates revenue from the sale of personal health products through retail channels and online platforms.
• Offers maintenance and support services for its installed base of medical equipment.
• Collaborates with healthcare providers and research institutions to develop new technologies and solutions.

What Industry Does PHG Operate In?

Koninklijke Philips N.V. operates within the rapidly evolving medical devices industry, characterized by technological advancements, increasing demand for healthcare services, and stringent regulatory requirements. Philips competes with major players like Mettler-Toledo International Inc. and DexCom, Inc., focusing on innovation and strategic partnerships to maintain its competitive edge. The industry is also witnessing a shift towards digital health solutions and AI-driven diagnostics, presenting both opportunities and challenges for companies like Philips.

Who Are PHG's Key Customers?

• Hospitals and clinics
• Healthcare providers
• Individual consumers
• Research institutions
• Government healthcare agencies

F-Score 8/9Financial Health

Koninklijke Philips N.V.'s Piotroski F-Score is 8/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.00 places it in the grey zone, a middle ground that warrants monitoring.

ROE 9%Key Financial Metrics

Return on equity for Koninklijke Philips N.V. stands at 9.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.6%, showing how much profit it generates from its asset base. PHG trades at a trailing price-to-earnings ratio of 23.19, roughly in line with the Healthcare sector average of ~23x. Its free cash flow yield is 8.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.32 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 4.3%, the inverse of the P/E and a quick read on earnings relative to price.

Koninklijke Philips N.V. (PHG) Valuation Context

Valued at $27.0B, PHG is classified as a large-cap stock. Relative to its peer group, PHG's quantitative score of 44/100 is below the peer average of 65/100.

FY2026 estForward Outlook

Wall Street analysts project Koninklijke Philips N.V. revenue of about $18.06B for fiscal 2026, with EPS near $1.54. The estimate reflects 10 contributing analysts.

PHG Financials

PHG Latest News

PHG Analyst Consensus

PHG MoonshotScore

What Investors Ask About Koninklijke Philips N.V. (PHG) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources